ULUte Linnenkamp

Ute Linnenkamp

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ute Linnenkamp has a total of 94 co-authors. Here are the top co-authors by number of shared publications:

  • Andrea Icks

    Institute for Health Services Research and Health Economics, Centre for Health and Society, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düssseldorf, Düsseldorf, Germany

    6 shared publications
  • Leonor Guariguata

    International Diabetes Federation, Brussels, Belgium

    6 shared publications
  • Barbara Hoffmann

    Institute for Occupational, Social and Environmental Medicine, Centre for Health and Society, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany

    4 shared publications
  • Imke Schmitz-Losem

    Pronova BKK, Statutory Health Insurance, Ludwigshafen, Germany

    4 shared publications
  • Johannes Kruse

    Clinic for Psychosomatic Medicine and Psychotherapy, University Clinics Gießen and Marburg, Giessen, Germany

    4 shared publications
  • Manuela Brüne

    Institute for Health Services Research and Health Economics, Centre for Health and Society, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düssseldorf, Düsseldorf, Germany

    4 shared publications

Latest Publications

  • Open Access

    Linked survey and statutory health insurance data evaluating healthcare utilization patterns and associated factors of persons with diabetes in Germany – latent class analysis

    by Ute Linnenkamp, Inga Deininghaus, Veronika Gontscharuk, Silke Andrich, Manuela Brüne, Nadezda Chernyak, Johannes Kruse, Mickaël Hiligsmann, Barbara Hoffmann, Andrea Icks

    Persons with diabetes mellitus have complex healthcare needs. Existing disease management programmes (DMPs) are based on a one-size-fits-all approach. However, individuals might require more individualised care. This study aims to identify groups with different patterns of healthcare utilization among people with diabetes in Germany and factors associated with these different patterns. A cross-sectional survey was conducted among a random sample from a statutory health insurance (SHI) with diabetes (n = 1332) and linked to longitudinal SHI data. Latent class analysis was used to identify subgroups with similar patterns of healthcare utilization and factors associated with different patterns. Four patterns of healthcare utilization were identified among people with diabetes: ‘low users’ (20.8% of the total sample); ‘low users with ophthalmologist visit’ (45.2%); ‘high users’ (26.5%); and ‘high users with mental health care’ (7.5%). The classes differed significantly in age, sex, type, duration and severity of diabetes, DMP membership, diabetes training, health-related quality of life, and prevalence of depression. The ‘high users with mental health care’ class was for example younger, more female, had a lower quality of life and the highest prevalence of depression. This study may provide a first basis for thinking about targeted care in Germany beyond DMPs.

  • Trends des Gestationsdiabetes in Deutschland

    by Gregory Gordon Greiner, Andrea Icks, Ute Linnenkamp

  • Open Access

    Prospective health care costs and lost work days associated with diabetes-related distress and depression symptoms among 1488 individuals with diabetes

    by Jana Sommer, Ute Linnenkamp, Veronika Gontscharuk, Silke Andrich, Manuela Brüne, Imke Schmitz-Losem, Johannes Kruse, Silvia M. A. A. Evers, Mickaël Hiligsmann, Barbara Hoffmann, et al.

    The aim of this study was to investigating the impact of major depression symptoms and diabetes-related distress on future health care costs and lost workdays in individuals with diabetes. We linked survey data from a random sample of a German statutory health insurance (SHI) with diabetes (n = 1488, 63.0% male, mean age 66.9 years) with their SHI data one year after the survey. Within the survey data we identified major depression symptoms (Patient Health Questionnaire-9) and diabetes-related distress (Problem Areas in Diabetes Scale). We retrieved health care costs and lost workdays from SHI data. To assess the impact of major depression symptoms and diabetes-related distress on health care costs and lost workdays, we adjusted regression models for age, sex, education, employment status, and diabetes duration, type, and severity. Major depression symptoms were associated with significantly higher costs (by a factor of 1.49; 95% CI: 1.18–1.88). Lost workdays were also more likely for respondents with depression symptoms (RR1.34; 0.97–1.86). Health care costs (by a factor of 0.81; 0.66–1.01) and the risk of lost workdays (RR 0.86; 0.62–1.18) may be lower among respondents with high diabetes-related distress. While major depression and diabetes-related distress have overlapping indicators, our results indicate different impacts on health care costs.


  • Nachsorge bei Gestationsdiabetes – von den Ergebnissen der Mixed-Methods-Studie GestDiNa_basic zu einem neuen Versorgungsmodell?

    by Gregory Gordon Greiner, Heinke Adamczewski, Regina Ensenauer, Tanja Fehm, Christian Graf, Viola Gräfe, Rebekka Hakenberg, Tim Hollmann, Peter Ihle, Matthias Kaltheuner, et al.

    Hintergrund Gestationsdiabetes (GDM) ist die häufigste Stoffwechselerkrankung während der Schwangerschaft und mit einem höheren Lebenszeitrisiko eines Typ-2-Diabetes mellitus assoziiert. Daher ist eine, den Bedarfen der Frauen gerechte, strukturierte GDM-Nachsorge bedeutsam. Jedoch fehlen Daten, inwiefern von GDM betroffene Frauen leitliniengerecht nachbetreut werden, welche Faktoren assoziiert sind oder wie das Zusammenspiel zwischen den behandelnden Leistungserbringenden funktioniert. Ziel des Projektes „Nachsorge bei Gestationsdiabetes“ (GestDiNa_basic) ist es, mittels eines Mixed-Methods-Ansatzes die Nachsorgesituation umfangreich abzubilden und ein patientinnenzentriertes und effektives Versorgungsmodell abzuleiten. Methoden Erkenntnisse aus quantitativen Daten (Register- und Abrechnungsdaten (GKV und KV)), schriftlichen Befragungen und qualitativen Interviews von Patientinnen und Leistungserbringenden verschiedener Professionen wurden gemeinsam betrachtet und gegenübergestellt. Methoden der deskriptiven, der analytischen Statistik (bspw. binomial logistische Regressionsmodelle) und der qualitativen Forschung (leitfadengestützte Interviews, Kraftfeldanalysen, Expertinnen-Salon) kamen zum Einsatz. Ergebnisse Etwa 40% der Frauen nehmen am postpartalen Screening teil. Positiv assoziiert mit der Teilnahme laut Register- und Abrechnungsdaten sind Insulinbehandlung, Alter, Vorerkrankungen, und Bildungsstatus; negativ assoziiert Migrationshintergrund, Rauchstatus, Laborwerte und BMI. Genannte Gründe zur (Nicht-)Teilnahme waren vielschichtig. Die Befragungen der Leistungserbringenden zeigten neben vielen Gemeinsamkeiten auch deutliche Unterschiede zwischen den Professionen in den jeweiligen Handlungsstandards und Ansichten, bspw. bei den Themen Zuständigkeit, Zusammenarbeit, Umgang mit Nachsorge, Informationsvermittlung und Rahmenbedingungen. Schlussfolgerung Für das (zum Zeitpunkt des Abstracts noch in der Ableitung befindliche) Versorgungsmodell ist neben der Integration der Sichtweisen der verschiedenen involvierten Leistungserbringenden (Diabetologie, Allgemeinmedizin, Gynäkologie, Geburtshilfe/Hebammen, Pädiatrie) insbesondere auch die Patientinnensicht –gewichtet für die Barrieren und Ressourcen innerhalb der Gruppen und in der Interaktion miteinander und unter Berücksichtigung der aktuellen Versorgungssituation– von zentraler Bedeutung. Greiner GG, Viehmann A, Linnenkamp U, Wilm S, Leve V, Neuenschwander M, Kuss O, Fehm T, Ensenauer R, Schumacher L, Lange U, Müller-Bößmann D, Lappe V, Ihle P, Adamczewski H, Kaltheuner M, Tamayo M, Gräfe V, Westerhoff B, Wallerich-Herf N, Schellhammer S, Kerres T, Schmitz-Losem I, Cramer S, Rupprecht CJ, Klüppelholz B, Meyer F, Koch-Schulte S, Jüngling U; GestDiNa study group; Icks A. Study protocol for a mixed methods exploratory investigation of aftercare services for gestational diabetes in women to develop a new patient-centred model in Germany: the GestDiNa_basic study. BMJ Open. 2021 Aug 2;11(8):e046048. doi: 10.1136/bmjopen-2020-046048 Article published online: 02 May 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    PHQ-9, CES-D, health insurance data—who is identified with depression? A Population-based study in persons with diabetes

    by Ute Linnenkamp, Veronika Gontscharuk, Katherine Ogurtsova, Manuela Brüne, Nadezda Chernyak, Tatjana Kvitkina, Werner Arend, Imke Schmitz-Losem, Johannes Kruse, Norbert Hermanns, et al.

    Aims: Several instruments are used to identify depression among patients with diabetes and have been compared for their test criteria, but, not for the overlaps and differences, for example, in the sociodemographic and clinical characteristics of the individuals identified with different instruments. Methods: We conducted a cross-sectional survey among a random sample of a statutory health insurance (SHI) (n = 1,579) with diabetes and linked it with longitudinal SHI data. Depression symptoms were identified using either the Centre for Epidemiological Studies Depression (CES-D) scale or the Patient Health Questionnaire-9 (PHQ-9), and a depressive disorder was identified with a diagnosis in SHI data, resulting in 8 possible groups. Groups were compared using a multinomial logistic model. Results: In total 33·0% of our analysis sample were identified with depression by at least one method. 5·0% were identified with depression by all methods. Multinomial logistic analysis showed that identification through SHI data only compared to the group with no depression was associated with gender (women). Identification through at least SHI data was associated with taking antidepressants and previous depression. Health related quality of life, especially the mental summary score was associated with depression but not when identified through SHI data only. Conclusion: The methods overlapped less than expected. We did not find a clear pattern between methods used and characteristics of individuals identified. However, we found first indications that the choice of method is related to specific underlying characteristics in the identified population. These findings need to be confirmed by further studies with larger study samples.


  • Open Access

    Postpartum screening of women with GDM in specialised practices: Data from 12,991 women in the GestDiab register

    by Ute Linnenkamp, Gregory Gordon Greiner, Burkhard Haastert, Heinke Adamczewski, Matthias Kaltheuner, Dietmar Weber, Andrea Icks

    Background: Gestational diabetes (GDM) in the short term is associated with various complications during pregnancy; however, in the long run, women have an increased risk of type 2 diabetes mellitus (T2DM). Therefore, short‐ and long‐term follow‐up postpartum is recommended.Methods: We assessed the proportion of postpartum diabetes screening among 12,991 women with their first GDM‐diagnosed pregnancy in the study period in the nationwide German GestDiab register between 2015 and 2017. In addition to assessing prevalence, we assessed if the probability of postpartum screening was associated with maternal characteristics or pregnancy outcomes.Results: In total, 38.2% (95% CI 32.8%–43.7%) of our sample underwent postpartum diabetes screening, irrespective of its timing. Around 50% of women (19.3% of the total sample) undertook the screening in the recommended time frame of 6–12 weeks postpartum. We found that age, native language, pre‐pregnancy BMI, smoking status, number of previous pregnancies, fasting plasma glucose and HbA1c levels as well as previous pregnancies with GDM and treatment with insulin were associated with participation in the postpartum diabetes screening in our sample.Conclusion: In our study, more than 60% of the women with GDM did not participate in postpartum diabetes screening. This is a missed opportunity in a high‐risk population to detect glucose intolerance. Consequently, appropriate interventions to prevent the progression to T2DM cannot be initiated. Further research should investigate barriers and enabling factors and allow developing a multilevel approach for GDM postpartum care.


  • Open Access

    Using statutory health insurance data to evaluate non-response in a cross-sectional study on depression among patients with diabetes in Germany

    by Ute Linnenkamp, Veronika Gontscharuk, Manuela Brüne, Nadezda Chernyak, Tatjana Kvitkina, Werner Arend, Annett Fiege, Imke Schmitz-Losem, Johannes Kruse, Silvia M A A Evers, et al.

    Background: Low response rates do not indicate poor representativeness of study populations if non-response occurs completely at random. A non-response analysis can help to investigate whether non-response is a potential source for bias within a study. Methods: A cross-sectional survey among a random sample of a health insurance population with diabetes (n = 3642, 58.9% male, mean age 65.7 years), assessing depression in diabetes, was conducted in 2013 in Germany. Health insurance data were available for responders and non-responders to assess non-response bias. The response rate was 51.1%. Odds ratios (ORs) for responses to the survey were calculated using logistic regression taking into consideration the depression diagnosis as well as age, sex, antihyperglycaemic medication, medication utilization, hospital admission and other comorbidities (from health insurance data). Results: Responders and non-responders did not differ in the depression diagnosis [OR 0.99, confidence interval (CI) 0.82–1.2]. Regardless of age and sex, treatment with insulin only (OR 1.73, CI 1.36–2.21), treatment with oral antihyperglycaemic drugs (OAD) only (OR 1.77, CI 1.49–2.09), treatment with both insulin and OAD (OR 1.91, CI 1.51–2.43) and higher general medication utilization (1.29, 1.10–1.51) were associated with responding to the survey. Conclusion: We found differences in age, sex, diabetes treatment and medication utilization between responders and non-responders, which might bias the results. However, responders and non-responders did not differ in their depression status, which is the focus of the DiaDec study. Our analysis may serve as an example for conducting non-response analyses using health insurance data.


  • Open Access

    Regional differences in antihyperglycemic medication are not explained by individual socioeconomic status, regional deprivation, and regional health care services. Observational results from the German DIAB-CORE consortium

    by Christina Bächle, Heiner Claessen, Werner Maier, Teresa Tamayo, Michaela Schunk, Ina-Maria Rückert-Eheberg, Rolf Holle, Christa Meisinger, Susanne Moebus, Karl-Heinz Jöckel, et al.

    This population-based study sought to extend knowledge on factors explaining regional differences in type 2 diabetes mellitus medication patterns in Germany. Individual baseline and follow-up data from four regional population-based German cohort studies (SHIP [northeast], CARLA [east], HNR [west], KORA [south]) conducted between 1997 and 2010 were pooled and merged with both data on regional deprivation and regional health care services. To analyze regional differences in any or newer anti-hyperglycemic medication, medication prevalence ratios (PRs) were estimated using multivariable Poisson regression models with a robust error variance adjusted gradually for individual and regional variables. The study population consisted of 1,437 people aged 45 to 74 years at baseline, (corresponding to 49 to 83 years at follow-up) with self-reported type 2 diabetes. The prevalence of receiving any anti-hyperglycemic medication was 16% higher in KORA (PR 1.16 [1.08–1.25]), 10% higher in CARLA (1.10 [1.01–1.18]), and 7% higher in SHIP (PR 1.07 [1.00–1.15]) than in HNR. The prevalence of receiving newer anti-hyperglycemic medication was 49% higher in KORA (1.49 [1.09–2.05]), 41% higher in CARLA (1.41 [1.02–1.96]) and 1% higher in SHIP (1.01 [0.72–1.41]) than in HNR, respectively. After gradual adjustment for individual variables, regional deprivation and health care services, the effects only changed slightly. Neither comprehensive individual factors including socioeconomic status nor regional deprivation or indicators of regional health care services were able to sufficiently explain regional differences in anti-hyperglycemic treatment in Germany. To understand the underlying causes, further research is needed.


  • Open Access

    External validation of type 2 diabetes computer simulation models: definitions, approaches, implications and room for improvement—a protocol for a systematic review

    by Katherine Ogurtsova, Thomas L. Heise, Ute Linnenkamp, Charalabos-Markos Dintsios, Stefan K. Lhachimi, Andrea Icks

    Type 2 diabetes mellitus (T2DM), a highly prevalent chronic disease, puts a large burden on individual health and health care systems. Computer simulation models, used to evaluate the clinical and economic effectiveness of various interventions to handle T2DM, have become a well-established tool in diabetes research. Despite the broad consensus about the general importance of validation, especially external validation, as a crucial instrument of assessing and controlling for the quality of these models, there are no systematic reviews comparing such validation of diabetes models. As a result, the main objectives of this systematic review are to identify and appraise the different approaches used for the external validation of existing models covering the development and progression of T2DM. We will perform adapted searches by applying respective search strategies to identify suitable studies from 14 electronic databases. Retrieved study records will be included or excluded based on predefined eligibility criteria as defined in this protocol. Among others, a publication filter will exclude studies published before 1995. We will run abstract and full text screenings and then extract data from all selected studies by filling in a predefined data extraction spreadsheet. We will undertake a descriptive, narrative synthesis of findings to address the study objectives. We will pay special attention to aspects of quality of these models in regard to the external validation based upon ISPOR and ADA recommendations as well as Mount Hood Challenge reports. All critical stages within the screening, data extraction and synthesis processes will be conducted by at least two authors. This protocol adheres to PRISMA and PRISMA-P standards. The proposed systematic review will provide a broad overview of the current practice in the external validation of models with respect to T2DM incidence and progression in humans built on simulation techniques. PROSPERO CRD42017069983 .